Reuters logo
BRIEF-Santarus up in premarket after FDA ok's ulcerative colitis dug
January 15, 2013 / 1:46 PM / 5 years ago

BRIEF-Santarus up in premarket after FDA ok's ulcerative colitis dug

NEW YORK, Jan 15 (Reuters) - Santarus Inc : * Up 8.6 percent premarket after FDA OK’s its oral drug to treat a type of inflammatory bowel disease

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below